Key terms
About PCVX
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PCVX news
Mar 12
6:39am ET
Vaxcyte price target raised to $113 from $69 at Mizuho
Mar 04
8:35am ET
Vaxcyte completes enrollment of Phase 2 study evaluating VAX-24
Mar 01
1:23am ET
Analysts Are Bullish on Top Healthcare Stocks: AdaptHealth (AHCO), LAVA Therapeutics (LVTX)
Mar 01
1:22am ET
Buy Rating Affirmed for Vaxcyte Amid Anticipation of Transformative VAX-31 Data Release
Mar 01
12:56am ET
Buy Rating Affirmed for Vaxcyte on Strong Vaccine Candidate Prospects and Upward Financial Projections
Feb 28
9:41am ET
Vaxcyte price target raised to $95 from $73 at Needham
Feb 28
7:23am ET
Vaxcyte price target raised to $98 from $76 at BTIG
Feb 28
7:06am ET
Vaxcyte’s VAX-31 Poised for Market Leadership: Shrader’s Bullish Forecast and Price Target Update
Feb 28
6:20am ET
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and Vaxcyte (PCVX)
Feb 28
5:29am ET
Buy Rating Affirmed for Vaxcyte Amid Strong Pipeline and Strategic R&D Investment
Feb 27
10:25pm ET
TD Cowen Remains a Buy on Vaxcyte (PCVX)
Feb 27
4:08pm ET
Vaxcyte reports Q 4 net loss $180.8M vs $78.1M last year
Feb 06
6:51am ET
Vaxcyte price target raised to $92 from $80 at BofA
Feb 06
5:51am ET
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Vaxcyte (PCVX) and Vertex Pharmaceuticals (VRTX)
Feb 01
1:23am ET
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), HCA Healthcare (HCA) and Sarepta Therapeutics (SRPT)
Jan 30
4:28pm ET
Vaxcyte offering $500M in common stock at $64 per share, Bloomberg says
Jan 30
4:03pm ET
Vaxcyte announces common stock, warrants offering, no amount given
Jan 29
8:51pm ET
Analysts Are Bullish on Top Healthcare Stocks: Ascendis Pharma (ASND), Sarepta Therapeutics (SRPT)
Jan 29
8:45pm ET
Vaxcyte price target raised to $76 from $69 at BTIG
Jan 16
4:08pm ET
Vaxcyte appoints Whitney Jones as Chief People Officer
Jan 15
12:55am ET
Vaxcyte’s Market Potential Unaffected by GSK’s Acquisition of Affinivax: A Buy Rating Rationale
Jan 09
1:50am ET
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), Xeris Pharmaceuticals (XERS) and IN8bio (INAB)
Jan 09
12:56am ET
Strong Buy Rating for Vaxcyte Amidst Promising Advancements and Strategic Positioning
Jan 07
5:39am ET
Vaxcyte (PCVX) Gets a Buy from BTIG
Jan 05
6:47am ET
Needham ups Phathom target, adds to Conviction List as top 2024 pick
Jan 04
4:08pm ET
Vaxcyte gives PCV franchise update, advances adult VAX-31 Phase 1/2 study
Jan 03
9:16am ET
Vaxcyte price target raised to $80 from $72 at Guggenheim
Jan 02
9:28am ET
Vaxcyte (PCVX) Gets a Buy from BTIG
Jan 02
9:08am ET
Vaxcyte price target raised to $80 from $67 at BofA
Dec 31
5:17am ET
BTIG Remains a Buy on Vaxcyte (PCVX)
No recent press releases are available for PCVX
PCVX Financials
Key terms
Ad Feedback
PCVX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PCVX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
